An Extension Study of a Drug to Treat CTEPH

• Research type

  Research Study

• Full title

  An open-label extension study of the long-term safety, tolerability and efficacy of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)

• IRAS ID

  131837

• Contact name

  Joanna Pepke-Zaba

• Contact email

  joanna.pepkezaba@papworth.nhs.uk

• Eudract number

  2012-001642-17

• ISRCTN Number

  n/a

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0168

• Date of REC Opinion

  2 Sep 2013

• REC opinion

  Further Information Favourable Opinion